Dr. Hugh Calkins is the Catherine Ellen Poindexter Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management. Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins. His first faculty position was at the University of Michigan, where he directed the Pacemaker Service, and he returned to Johns Hopkins as director of the Arrhythmia Service in 1992. Dr. Calkins is an Associate Editor of the Journal of Cardiovascular Electrophysiology and is on the editorial board of many other cardiology journals. He is a former member of the American Board of Internal Medicine Electrophysiology Boards Test Writing Committee. Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miler Coulsen Academy of Clinical Excellence in 2014. Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. Dr. Calkins is rated as an Elite provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Dr. Andreas S. Barth is an Associate Professor in the Division of Cardiology at the Johns Hopkins School of Medicine and Director of the Center for Inherited Heart Diseases. His clinical work focuses on clinical cardiac electrophysiology with a specific focus on inherited arrhythmia syndromes and channelopathies, including long QT syndrome, Brugada syndrome, CPVT and arrhythmogenic cardiomyopathies. Additionally, Dr. Barth participates in a multidisciplinary clinic at Kennedy Krieger Institute providing Cardiology care to patients with muscular dystrophies and mitochondrial disease. Dr. Barth performs pacemaker and defibrillator implantation and complex catheter ablations for atrial and ventricular arrhythmias. His basic research lab explores the relationship between metabolic and arrhythmogenic ion channel remodeling in heart failure and myotonic dystrophy. Dr. Barth earned a combined doctor of medicine and doctor of philosophy from the Ludwig-Maximilians-University in Munich, Germany. He joined the Johns Hopkins faculty in 2016. He has been recognized with the First Prize for the Stanley L. Blumenthal Cardiology Research Award in Clinical Science in the Division of Cardiology at Johns Hopkins Hospital, and as a Young Investigator Award Finalist of the American Heart Association and Heart Rhythm Society. Dr. Barth is rated as a Distinguished provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Cardiomyopathy, Arrhythmias, Heart Attack, Cardiac Ablation, and Pacemaker Implantation.

Daniel Judge is a Cardiologist in Baltimore, Maryland. Dr. Judge is rated as an Elite provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation.

Vikas Kalra is a Cardiac Electrophysiologist and a Cardiologist in Towson, Maryland. Dr. Kalra is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Atrial Fibrillation, Bidirectional Tachycardia, Catecholaminergic Polymorphic Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation. Dr. Kalra is currently accepting new patients.

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as a Distinguished provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. Her top areas of expertise are Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Stephen Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as an Advanced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Angina, and Apoplexy.

Ronald Schechter is a Cardiologist in Towson, Maryland. Dr. Schechter is rated as an Advanced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Cardiomyopathy, Necrosis, Atherosclerosis, and Coronary Heart Disease.

Daniel Plotnick is a Cardiologist in Towson, Maryland. Dr. Plotnick is rated as an Advanced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Apoplexy, Aortic Regurgitation, Atrial Fibrillation, and Cardiomyopathy.

Dr. Stacy Fisher is a cardiologist in Baltimore, Maryland specializing in the care of adult congenital heart disease, pregnancy-related heart disease and congenital heart pulmonary hypertension. She is Associate Director of the Adult Congenital Heart Disease (ACHD) Center at the Johns Hopkins Heart and Vascular Institute and Director of the ACHD Training Program. She is also an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her research focus is congenital heart disease in adults including pulmonary hypertension, inherited heart disease and 3D printing translational medicine. She is interested in imaging and using 3D modeling to advance cardiac care and education. Her education includes a Bachelor of Science degree in Microbiology from Miami University in Oxford, Ohio, and a Doctor of Medicine Degree from the University of Maryland School of Medicine in Baltimore, Maryland. She completed an internship and residency in Internal Medicine at Duke University in Durham, North Carolina. Her fellowship in cardiology was at the University of Rochester, Strong Memorial Hospital in Rochester, New York, including serving as the Chief Cardiology Fellow. She was then an Adult Congenital Heart Fellow at the University of Rochester, Strong Memorial Hospital. After completing her fellowship in 2001, she joined a Baltimore cardiology practice and was named Director of Women’s Cardiovascular Services and the Co-Director of the Cardiac Critical Care Unit at Sinai Hospital in Baltimore, positions which she held until 2011. She then joined University of Maryland School of Medicine as Director of Women’s and Complex Heart diseases where she started and directed the Adult Congenital Heart Program and practiced through 2022 when she joined Johns Hopkins. She was recently the President of the American Heart Association’s Greater Maryland Region. Videos Dr. Stacy Fisher. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. Her top areas of expertise are Familial Ventricular Tachycardia, Arrhythmias, Ventricular Tachycardia, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Reed David Riley is an assistant professor of medicine at the Johns Hopkins University School of Medicine and chief of cardiology at the Greater Baltimore Medical Center. Dr. Riley received his undergraduate degree from Duke University. He earned a medical degree from The Johns Hopkins University School of Medicine and completed a residency at Johns Hopkins Hospital. Prior to joining Johns Hopkins in 2007, Dr. Riley was a cardiology fellow at Duke University and staff cardiologist at Sinai Hospital of Baltimore. He is currently also a teaching attending on the Osler Medical Service’s Barker Firm at the Johns Hopkins Hospital. Dr. Riley is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Heart Attack, Atrial Fibrillation, Apoplexy, and Angina.

Sabra Lewsey is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. Dr. Lewsey earned her medical degree from Columbia University College of Physicians & Surgeons and a master of public health degree from Harvard School of Public Health. She completed her residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Lewsey is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. Her top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, and Heart Transplant.

Jonathan Chrispin, M.D., is an Associate Professor of Medicine in the Johns Hopkins Medicine Division of Cardiology, Electrophysiology and Arrhythmia, as well as an Associate Professor of Biomedical Engineering at Johns Hopkins University. Dr. Chrispin focuses on all aspects of clinical electrophysiology, including pacemaker/defibrillator implantation and complex catheter ablation for atrial and ventricular arrhythmias. Dr. Chrispin received his Bachelor of Arts degree from Harvard University. He received his Doctor of Medicine degree from Vanderbilt University. He completed intern and residency training in internal medicine at The Johns Hopkins Hospital, where he also completed a fellowship in cardiovascular disease and served as chief clinical cardiac electrophysiology fellow. He is a member of the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society. Dr. Chrispin directs the Ventricular Arrhythmia Ablation and Research program, focusing on using advanced cardiac imaging to better understand the structural substrate associated with the development of ventricular arrhythmias and using artificial intelligence to improve the risk stratification of sudden cardiac death. Further, he is involved in developing clinical trials to improve the safety and efficacy of catheter ablation for the treatment of ventricular tachycardia. His work has led to Dr. Chrispin publishing in a number of international journals, including Circulation, the Journal of the American College of Cardiology, Heart Rhythm Journal, Nature Cardiovascular Research, Journal of the American Heart Association, and EP Europace. Dr. Chrispin is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Sarcoidosis, Cardiac Ablation, and Pacemaker Implantation.

Paul Scheel, M.D., is a cardiologist at Johns Hopkins Medicine in Baltimore, Maryland with an expertise in Advanced Heart Failure and Transplant Cardiology. He is also an Assistant Professor of Medicine at the Johns Hopkins School of Medicine. Dr. Scheel provides clinical care to patients with heart failure, treating a wide range of conditions. He is an integral part of the Advanced Heart Failure and CCU inpatient services, and also provides service in the Cath Lab. Dr. Scheel earned his B.S. degree from the University of Notre Dame, majoring in Chemical and Biomolecular Engineering and minoring in Bioengineering. He obtained his M.D. degree from Washington University in St. Louis School of Medicine, where he was elected Alpha Omega Alpha. Following his medical degree, Dr. Scheel embarked on his training at Johns Hopkins Hospital. He completed his internship in Internal Medicine in 2017, followed by residency in Internal Medicine from 2017 to 2019. Driven by his passion for cardiovascular disease, he then pursued a fellowship in Cardiovascular Disease from 2019 to 2022. Building upon this foundation, he continued his training with a fellowship in Advanced Heart Failure and Transplant Cardiology, further honing his expertise in managing complex heart failure cases. He has been involved in research within the ARVC and LVAD Programs at Johns Hopkins and has a wider interest in genetic cardiomyopathies and durable mechanical support. Dr. Scheel is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Heart Failure, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiomyopathy, Pulmonary Edema, and Heart Transplant.

Dr. Jennifer Tanio is a cardiologist at the Johns Hopkins Health Care and Surgery Center at Green Spring Station. Dr. Tanio received her B.A. from Johns Hopkins University and her M.D. from the University of Pennsylvania School of Medicine. She completed her residency at the University of Pennsylvania and pursued cardiology fellowships at the University of Pennsylvania and the Johns Hopkins University School of Medicine. Dr. Tanio worked in private practice before joining the Johns Hopkins cardiology faculty. Dr. Tanio’s clinical expertise includes preventive cardiology and heart disease. Dr. Tanio is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. Her top areas of expertise are Mitral Valve Prolapse, Heart Attack, Atherosclerosis, and Coronary Heart Disease.

Ali Salah is a Cardiologist in Baltimore,, Maryland. Dr. Salah is rated as an Advanced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Pediatric Myocarditis, Aortic Regurgitation, Familial Ventricular Tachycardia, and Inappropriate Sinus Tachycardia (IST).

Samer Najjar is a Cardiologist in Baltimore,, Maryland. Dr. Najjar is rated as an Advanced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Heart Failure, Cardiomyopathy, Cardiogenic Shock, Heart Transplant, and Cardiac Ablation.

Julia Cadrin is a Cardiologist in Baltimore,, Maryland. Dr. Cadrin is rated as a Distinguished provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. Her top areas of expertise are Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiac Arrest, Familial Hypertrophic Cardiomyopathy, and Cardiac Ablation.

Jeremy Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Atrial Fibrillation, Heart Attack, and Apoplexy.

Mark Kelemen is a Cardiologist in Baltimore, Maryland. Dr. Kelemen is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. His top areas of expertise are Apoplexy, Pulmonary Edema, Heart Failure, Heart Attack, and Pacemaker Implantation.

Nicole Minkove is a Cardiologist in Towson,, Maryland. Dr. Minkove is rated as an Experienced provider by MediFind in the treatment of Arrhythmogenic Right Ventricular Cardiomyopathy. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Giant Cell Myocarditis, and Cardiomyopathy.